NYSE · RJF
Raymond James Financial, Inc.
$161.29+$3.87 (+2.46%)
Raymond James Financial, Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.73% below the high.
Loading market information…
NYSE · MC · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Moelis & Company’s quoted price sits in the lower half of its reported 52-week range, 23.32% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Moelis & Company’s forward annual dividend is $2.60 per share, paid quarterly. The forward yield is 4.33% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Moelis & Company’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of $0.72. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Moelis & Company’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Moelis & Company operates as a dedicated investment banking advisory firm, offering expert counsel on a wide range of corporate finance matters. Its core services include strategic guidance for mergers and acquisitions (M&A), corporate recapitalizations and restructurings, and capital market transactions. The firm serves a diverse global client base, which encompasses large public multinational corporations, private middle-market businesses, financial sponsors, entrepreneurs, governmental organizations, and sovereign wealth funds. With operations spanning North and South America, Europe, the Middle East, Asia, and Australia, Moelis & Company also leverages strategic alliances, specifically with Alfaro, Dávila y Scherer, S.C. in Mexico and MA Moelis Australia. Founded in 2007, the company's headquarters are situated in New York, New York.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:38 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | Apr 23, 2025 | $0.64+15.32% vs estimate | $306.59M+6.53% vs estimate |
|---|
| Q4 2024 | Feb 5, 2025 | $1.18+202.56% vs estimate | $438.72M+25.78% vs estimate |
|---|
| Q3 2024 | Oct 23, 2024 | $0.22+4.76% vs estimate | $273.76M-16.74% vs estimate |
|---|
THE ANALYST VIEW
22 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 5 contributors · Median target $62.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$161.29+$3.87 (+2.46%)
Raymond James Financial, Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.73% below the high.
$66.44-$3.02 (-4.35%)
Hut 8 Corp.’s quoted price sits in the lower half of its reported 52-week range, 52.81% below the high.
$54.92-$1.12 (-2.0%)
StoneX Group Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.98% below the high.
$164.92+$0.10 (+0.06%)
MarketAxess Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 15.84% below the high.
$2,245.46+$36.88 (+1.67%)
White Mountains Insurance Group, Ltd.’s quoted price sits in the upper half of its reported 52-week range, 3.75% below the high.
$11.42-$0.02 (-0.17%)
BGC Group, Inc’s quoted price sits in the upper half of its reported 52-week range, 11.4% below the high.
$68.72+$1.76 (+2.63%)
Piper Sandler Companies’s quoted price sits in the lower half of its reported 52-week range, 27.72% below the high.
$54.21-$1.23 (-2.22%)
Virtu Financial, Inc.’s quoted price sits in the upper half of its reported 52-week range, 21.16% below the high.
